China is the pharma industry’s biggest gainer in the 2021 CPhI Annual Rankings, with digital matchmaking driving new waves of partnerships China’s pharma industry has …
Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological field. According to Sy …
WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces …
Discussions extended for China and other rights Athersys, Inc. (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. (“Healios”) to expand …
45,000 industry experts attend as intelligent manufacturing and new environmental policies identified as key medium term trends P-MEC China will be held at the Shanghai …
2018 event prepares for surge in international attendees as MAH nears national rollout CPhI & P-MEC China (#CPhIChina) – organized by UBM and UBM SINEXPO …
China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st China has removed import duties on as many as …
From March 20-23, 2018, the 6th DPI Dry Powder Technology China Technology Conference in Shanghai bringing almost 300 participants from the Chinese pharmaceutical industry together, …
LCHINA is the first and only stock market index available to the public that follows China’s biopharma industry from both its regional and U.S. listed …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
